3,239 Shares in Humana Inc. (NYSE:HUM) Bought by Liberty One Investment Management LLC

Liberty One Investment Management LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 3,239 shares of the insurance provider’s stock, valued at approximately $822,000.

Several other institutional investors have also recently bought and sold shares of HUM. Clarius Group LLC raised its stake in shares of Humana by 7.0% in the fourth quarter. Clarius Group LLC now owns 905 shares of the insurance provider’s stock worth $230,000 after purchasing an additional 59 shares during the last quarter. Canoe Financial LP bought a new stake in Humana during the fourth quarter worth $62,000. Merit Financial Group LLC raised its position in Humana by 16.6% in the 4th quarter. Merit Financial Group LLC now owns 1,819 shares of the insurance provider’s stock valued at $461,000 after buying an additional 259 shares during the last quarter. Avanza Fonder AB bought a new position in Humana during the 4th quarter valued at $2,524,000. Finally, Beech Hill Advisors Inc. purchased a new position in Humana during the 4th quarter worth $207,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

Humana stock opened at $282.63 on Friday. The firm has a market capitalization of $34.03 billion, a P/E ratio of 25.03, a PEG ratio of 2.02 and a beta of 0.55. Humana Inc. has a one year low of $213.31 and a one year high of $415.73. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The business has a fifty day moving average price of $273.81 and a 200-day moving average price of $308.04.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. As a group, equities research analysts forecast that Humana Inc. will post 16.14 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Analyst Ratings Changes

A number of research analysts recently weighed in on HUM shares. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and raised their price target for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Piper Sandler lifted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price for the company in a report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft dropped their price target on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Finally, TD Cowen upped their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $302.70.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.29% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.